本文選題：中醫(yī)藥 + 知識產(chǎn)權(quán)保護��； 參考：《南京中醫(yī)藥大學》2015年碩士論文

【摘要】：目前,西方發(fā)達國家正逐步將中醫(yī)藥推為“公共知識”,而不是將其作為知識產(chǎn)權(quán)的一種保護對象,并正在對其進行著無償商業(yè)性開發(fā)和盈利,這無疑加速了我國中醫(yī)藥知識產(chǎn)權(quán)的流失。中醫(yī)藥知識產(chǎn)權(quán)的流失不僅會損害本土中醫(yī)藥企業(yè)及國家的整體利益,還將阻礙本土中醫(yī)藥品牌及產(chǎn)業(yè)的可持續(xù)發(fā)展,進而對我國中醫(yī)藥產(chǎn)業(yè)的國際化進程造成威脅。因此,加強我國中醫(yī)藥知識產(chǎn)權(quán)保護,實現(xiàn)并維護好我國傳統(tǒng)中醫(yī)藥知識的利益,對中醫(yī)藥產(chǎn)業(yè)安全具有深遠影響�；谥R產(chǎn)權(quán)保護,探索我國的中醫(yī)藥產(chǎn)業(yè)安全,不僅具有理論價值,更具有重要的現(xiàn)實意義。本研究以中醫(yī)藥知識產(chǎn)權(quán)保護為視角,探討中醫(yī)藥產(chǎn)業(yè)安全問題,所作研究主要包括以下幾個方面：(1)通過大量的文獻檢索和閱讀,在對影響中醫(yī)藥產(chǎn)業(yè)安全的知識產(chǎn)權(quán)要素進行分析的基礎(chǔ)上,進行指標體系的初步設(shè)計,將中醫(yī)藥產(chǎn)業(yè)知識產(chǎn)權(quán)保護水平從產(chǎn)業(yè)國內(nèi)環(huán)境中分離出來,并將其作為目前我國中醫(yī)藥知識產(chǎn)權(quán)保護的制度環(huán)境重點考察。(2)針對初建的指標體系進行第一輪專家咨詢,通過統(tǒng)計分析對指標體系進行篩選,并通過因子分析對篩選后的指標體系進行結(jié)構(gòu)檢驗,最終確立了包含中醫(yī)藥產(chǎn)業(yè)知識產(chǎn)權(quán)保護水平、知識產(chǎn)權(quán)保護背景下中醫(yī)藥產(chǎn)業(yè)自主創(chuàng)新水平、中醫(yī)藥產(chǎn)業(yè)國內(nèi)環(huán)境及知識產(chǎn)權(quán)保護背景下中醫(yī)藥產(chǎn)業(yè)競爭力四個維度的評價指標體系。(3)針對指標權(quán)重進行第二輪專家咨詢,利用層次分析法,確定指標權(quán)重。(4)在對因素層進行現(xiàn)狀分析的基礎(chǔ)上進行第三輪專家咨詢,以獲取專家對于各指標的評價結(jié)果及評價值,并利用物元可拓模型對中醫(yī)藥產(chǎn)業(yè)安全進行多級可拓評價。研究發(fā)現(xiàn),中醫(yī)藥產(chǎn)業(yè)國內(nèi)環(huán)境處于基本安全狀態(tài),而知識產(chǎn)權(quán)保護水平、知識產(chǎn)權(quán)保護背景下自主創(chuàng)新水平和競爭力均處于不安全狀態(tài)。從產(chǎn)業(yè)整體來看,中醫(yī)藥產(chǎn)業(yè)整體呈現(xiàn)出不安全狀態(tài)。最后,基于研究結(jié)果,圍繞知識產(chǎn)權(quán)保護提出了相關(guān)對策和建議。
[Abstract]:At present, the western developed countries are gradually pushing traditional Chinese medicine into "public knowledge", instead of taking it as a protection object of intellectual property, and is carrying out unpaid commercial exploitation and profit. This undoubtedly accelerates the loss of intellectual property rights of Chinese medicine. The loss of intellectual property rights of traditional Chinese Medicine will not only damage local traditional Chinese medicine enterprises. The overall interests of the industry and the state will also impede the sustainable development of local traditional Chinese medicine brand and industry, and then threaten the internationalization of Chinese traditional Chinese medicine industry. Therefore, strengthening the protection of intellectual property rights of Chinese medicine, realizing and maintaining the interests of the knowledge of traditional Chinese medicine, has far-reaching influence on the safety of traditional Chinese medicine industry. In the protection of intellectual property, the exploration of the safety of Chinese medicine industry is not only of theoretical value but also of great practical significance. In this study, the problem of the safety of traditional Chinese medicine industry is discussed with the protection of intellectual property rights of traditional Chinese medicine as the angle of view. The research mainly includes the following aspects: (1) through a large number of literature retrieval and reading, the impact of the study is on the influence of Chinese medicine. On the basis of the analysis of the intellectual property factors of the medical industry safety, the preliminary design of the index system is carried out, the intellectual property protection level of the Chinese medicine industry is separated from the domestic environment, and the system environment of the intellectual property protection of Chinese medicine is reviewed. (2) the first built index system is carried out. A round of expert consultation, through the statistical analysis of the index system screening, and through the factor analysis of the selected index system to test the structure, and finally established the level of intellectual property protection including the traditional Chinese medicine industry, the level of independent innovation of traditional Chinese medicine industry under the background of intellectual property protection, the domestic environment of traditional Chinese medicine industry and intellectual property protection. The evaluation index system of the four dimensions of the competitiveness of Chinese medicine industry under the background of protecting the background. (3) second rounds of expert consultation on the index weight and the use of analytic hierarchy process (AHP) to determine the weight of the index. (4) a third round of expert consultation is carried out on the basis of the status analysis of the factor layer, in order to obtain the evaluation results and evaluation values of the experts on each index, and The multilevel extension evaluation of traditional Chinese medicine industry safety is carried out by the matter element extension model. It is found that the domestic environment of the Chinese medicine industry is in the basic state of security, while the level of intellectual property protection and the independent innovation level and competitiveness under the background of intellectual property protection are insecure. From the whole industry, the whole Chinese medicine industry presents Finally, based on the research results, relevant countermeasures and suggestions are put forward around the protection of intellectual property rights.
【學位授予單位】：南京中醫(yī)藥大學
【學位級別】：碩士
【學位授予年份】：2015
【分類號】：F426.72;F204;R288

【參考文獻】

相關(guān)期刊論文 前10條

1 尹莉娟;趙銀德;張立強;許鮮欣;;我國中藥材出口競爭力分析及策略[J];安徽農(nóng)業(yè)科學;2010年25期

2 張董;;知識產(chǎn)權(quán)對我國中醫(yī)藥產(chǎn)業(yè)國際化影響的實證分析[J];經(jīng)營管理者;2009年08期

3 王鍵;黃輝;;中醫(yī)學與中華傳統(tǒng)文化(一)[J];中醫(yī)藥臨床雜志;2011年01期

4 林維勇;張小平;王喜賓;;基于灰關(guān)聯(lián)分析構(gòu)建中藥現(xiàn)代化產(chǎn)業(yè)績效評估指標體系[J];貴州大學學報(自然科學版);2012年04期

5 王治彪;;中醫(yī)藥產(chǎn)業(yè)安全的思考[J];北京理工大學學報(社會科學版);2013年06期

6 林仲源;秦藝蓉;蔡鴻;;基于熵值法的我國中醫(yī)藥產(chǎn)業(yè)競爭力實證研究[J];產(chǎn)業(yè)與科技論壇;2014年03期

7 紀媛媛;;從知識產(chǎn)權(quán)角度淺談拜耳收購中藥企業(yè)的產(chǎn)業(yè)安全思考[J];中國發(fā)明與專利;2015年02期

8 何維達;李冬梅;;我國產(chǎn)業(yè)安全理論研究綜述[J];經(jīng)濟縱橫;2006年08期

9 索貴彬;趙國杰;;基于灰色可拓物元模型的企業(yè)技術(shù)創(chuàng)新風險度量研究[J];科學管理研究;2008年01期

10 王立平;劉平;呂波;張新明;周建仁;;我國農(nóng)林植物新品種保護現(xiàn)狀與展望[J];中國農(nóng)業(yè)科技導報;2010年06期

相關(guān)重要報紙文章 前1條

1 本報評論員 吳瀟湘;[N];中國中醫(yī)藥報;2013年

相關(guān)博士學位論文 前1條

1 鄭寶華;中國醫(yī)藥制造業(yè)產(chǎn)業(yè)安全及其評價研究[D];南京航空航天大學;2010年

相關(guān)碩士學位論文 前2條

1 王魏云;中醫(yī)藥知識產(chǎn)權(quán)保護及品牌戰(zhàn)略研究[D];武漢理工大學;2008年

2 張董;我國中醫(yī)藥產(chǎn)業(yè)國際化發(fā)展的知識產(chǎn)權(quán)問題研究[D];中國海洋大學;2009年

，

本文編號：1934996